158 related articles for article (PubMed ID: 38092950)
1. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities mediate the association between frailty and cognitive impairment in moyamoya disease.
Du J; Qu C; Xu Z; Liu Z; Lv M; Wang D; Wei W; Duan Y; Shen J
Clin Neurol Neurosurg; 2024 May; 240():108283. PubMed ID: 38608350
[TBL] [Abstract][Full Text] [Related]
3. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.
Liu Y; Wu L; Yang C; Xian W; Zheng Y; Zhang C; Hong G; Jiang L; Yang Z; Pei Z; Liu J; Chen L
J Neurol Sci; 2020 Nov; 418():117121. PubMed ID: 32950863
[TBL] [Abstract][Full Text] [Related]
4. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
[TBL] [Abstract][Full Text] [Related]
5. White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke.
Zamboni G; Griffanti L; Jenkinson M; Mazzucco S; Li L; Küker W; Pendlebury ST; Rothwell PM;
Stroke; 2017 Jun; 48(6):1539-1547. PubMed ID: 28487328
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic hyperintensity pathways are associated with cognitive performance in patients with asymptomatic carotid artery stenosis.
Xu S; Yu S; Mao B; Yang J; Jiang P; Wan S; Fu F
Clin Neurol Neurosurg; 2024 Jun; 241():108278. PubMed ID: 38631155
[TBL] [Abstract][Full Text] [Related]
7. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
8. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
9. White Matter Hyperintensities Predict Cognitive Decline: A Community-Based Study.
Qi X; Tang H; Luo Q; Ding B; Chen J; Cui P; Chen S; Ling H; Ma J
Can J Neurol Sci; 2019 Jul; 46(4):383-388. PubMed ID: 31133080
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
Lim JS; Kwon HM; Lee YS
Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities in cholinergic pathways are associated with dementia severity in e4 carriers but not in non-carriers.
Yu MC; Chuang YF; Wu SC; Ho CF; Liu YC; Chou CJ
Front Neurol; 2023; 14():1100322. PubMed ID: 36864910
[TBL] [Abstract][Full Text] [Related]
12. Cerebral white matter burden is linked to cognitive function in patients undergoing hemodialysis.
Wu TS; Wu PH; Lin HF; Chen WC; Huang TH; Lin MY; Chuang YS; Yang FG; Chiu YW; Chang JM; Kuo MC; Lin YT
Ann Med; 2024 Dec; 56(1):2310142. PubMed ID: 38324920
[TBL] [Abstract][Full Text] [Related]
13. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
Kim SH; Kang HS; Kim HJ; Moon Y; Ryu HJ; Kim MY; Han SH
J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
[TBL] [Abstract][Full Text] [Related]
14. A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.
Kimura Y; Sato N; Ota M; Maikusa N; Maekawa T; Sone D; Enokizono M; Sugiyama A; Imabayashi E; Matsuda H; Okamoto T; Yamamura T; Sugimoto H
eNeurologicalSci; 2017 Sep; 8():11-16. PubMed ID: 29260029
[TBL] [Abstract][Full Text] [Related]
15. Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism.
Park HE; Park IS; Oh YS; Yang DW; Lee KS; Choi HS; Ahn KJ; Kim JS
J Neurol Sci; 2015; 353(1-2):44-8. PubMed ID: 25891829
[TBL] [Abstract][Full Text] [Related]
16. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
[TBL] [Abstract][Full Text] [Related]
17. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
18. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
Rane S; Owen J; Hippe DS; Cholerton B; Zabetian CP; Montine T; Grabowski TJ
J Neuroimaging; 2020 Nov; 30(6):843-850. PubMed ID: 32937003
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
Lee LH; Wu SC; Ho CF; Liang WL; Liu YC; Chou CJ
PLoS One; 2023; 18(3):e0283790. PubMed ID: 37000849
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
